Loading... Please wait... Loading... Please wait...
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction | Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
Galbraith KennethCEO |
Sell | 5,706 @ $11.22 | $63,996 | 23,762 | 01/08/2024 | 01/08/2024 | |
Astle ChristopherSVP & CFO |
Sell | 1,431 @ $11.22 | $16,050 | 6,503 | 01/08/2024 | 01/08/2024 | |
Moore Paul AndrewChief Scientific Officer |
Sell | 2,339 @ $11.22 | $26,233 | 7,367 | 01/08/2024 | 01/08/2024 | |
Galbraith KennethCEO |
Sell | 18,198 @ $10.65 | $193,849 | 29,468 | 01/05/2024 | 01/08/2024 | |
Astle ChristopherSVP & CFO |
Sell | 4,563 @ $10.65 | $48,606 | 7,934 | 01/05/2024 | 01/08/2024 | |
Moore Paul AndrewChief Scientific Officer |
Sell | 7,460 @ $10.65 | $79,465 | 9,706 | 01/05/2024 | 01/08/2024 | |
EcoR1 Capital, LLC10 percent owner |
Buy | 5,086,521 @ $0.00 | $509 | 5,086,521 | 12/26/2023 | 12/28/2023 | |
Astle ChristopherSVP & CFO |
Sell | 886 @ $9.13 | $8,089 | 1,997 | 12/11/2023 | 12/11/2023 | |
EcoR1 Capital, LLC10 percent owner |
Buy | 3,350,000 @ $8.12 | $27.20 M | 13,437,473 | 06/16/2023 | 06/21/2023 | |
EcoR1 Capital, LLC10 percent owner |
Buy | 200,000 @ $8.00 | $1.60 M | 10,087,473 | 03/28/2023 | 03/30/2023 | |
Klompas Neil APresident & COO |
Sell | 2,977 @ $7.83 | $23,298 | 17,032 | 03/10/2023 | 03/14/2023 | |
EcoR1 Capital, LLCdirector |
Buy | 163,400 @ $9.88 | $1.62 M | 9,887,473 | 01/20/2023 | 01/23/2023 | |
EcoR1 Capital, LLCdirector |
Buy | 144,100 @ $9.49 | $1.37 M | 9,724,073 | 01/19/2023 | 01/23/2023 | |
EcoR1 Capital, LLCdirector |
Buy | 203,000 @ $10.00 | $2.03 M | 9,579,973 | 01/18/2023 | 01/18/2023 | |
EcoR1 Capital, LLCdirector |
Buy | 440,000 @ $9.80 | $4.31 M | 9,376,973 | 01/17/2023 | 01/18/2023 | |
EcoR1 Capital, LLCdirector |
Buy | 342,100 @ $9.81 | $3.35 M | 8,936,973 | 01/13/2023 | 01/18/2023 | |
EcoR1 Capital, LLCdirector |
Buy | 106,300 @ $7.87 | $836,911 | 8,594,873 | 01/11/2023 | 01/12/2023 | |
EcoR1 Capital, LLCdirector |
Buy | 920,000 @ $7.65 | $7.04 M | 8,488,573 | 01/10/2023 | 01/12/2023 | |
Josephson NeilChief Medical Officer |
Sell | 2,475 @ $8.10 | $20,045 | 14,449 | 11/10/2022 | 11/14/2022 | |
Redmile Group, LLC10 percent owner |
Buy | 30,481 @ $5.03 | $153,435 | 6,075,918 | 10/13/2022 | 10/18/2022 |
| Member of congress | Current Price | Type | Trade Data | Date Filed | Date Traded |
|---|
A. The list of insiders at Zymeworks Inc. includes Astle Christopher, EcoR1 Capital, LLC, Moore Paul Andrew, Galbraith Kenneth.
A. Insiders have sold a total of 40,583 Zymeworks Inc. shares in the last 12 months for a total of 436,288 sold.
A. The following insiders have sold Zymeworks Inc. shares in the last 12 months: Astle Christopher ($72,745), Moore Paul Andrew ($105,699), Galbraith Kenneth ($257,845),
A. Insiders have purchased a total of 5.09 M Zymeworks Inc. shares in the last 12 months for a total of 509 sold.
A. The following insiders have purchased Zymeworks Inc. shares in the last 12 months: EcoR1 Capital, LLC ($509),
